Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Pardini

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Clinical Nutrition (Edinburgh, Scotland)|February 29, 2024
Modulation of faecal miRNAs highlights the preventive effects of a Mediterranean low-inflammatory dietary interventionOscar Illescas, Giulio Ferrero, Antonino Belfiore, et al.
Molecular Carcinogenesis|July 22, 2016
H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancerValentina Turinetto, Barbara Pardini, Alessandra Allione, et al.
Gastroenterology|June 1, 2023
A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter StudyBarbara Pardini, Giulio Ferrero, Sonia Tarallo, et al.
The Journal of Pathology|January 18, 2024
A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restrictionGil A Pastorino, Ilir Sheraj, Kerstin Huebner, et al.
Plos One|March 8, 2012
A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancerDaniele Campa, Juan Sainz, Barbara Pardini, et al.
Molecular Medicine (Cambridge, Mass.)|April 2, 2022
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancerTudor Moisoiu, Mihnea P Dragomir, Stefania D Iancu, et al.
International Journal of Cancer|April 5, 2013
Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapyCarlotta Sacerdote, Simonetta Guarrera, Fulvio Ricceri, et al.
BMC Gastroenterology|October 6, 2010
Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control studyDaniele Campa, Barbara Pardini, Alessio Naccarati, et al.
British Journal of Cancer|June 12, 2026
Fecal immunochemical tests from population-based colorectal cancer screening programs support prospective microbiome cohortsDoratha A Byrd, Sémi Zouiouich, David Wahl, et al.
Plos One|June 16, 2011
Association between TAS2R38 gene polymorphisms and colorectal cancer risk: a case-control study in two independent populations of Caucasian originMaura Carrai, Verena Steinke, Pavel Vodicka, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Clinical Nutrition (Edinburgh, Scotland)|February 29, 2024
Modulation of faecal miRNAs highlights the preventive effects of a Mediterranean low-inflammatory dietary interventionOscar Illescas, Giulio Ferrero, Antonino Belfiore, et al.
Molecular Carcinogenesis|July 22, 2016
H2AX phosphorylation level in peripheral blood mononuclear cells as an event-free survival predictor for bladder cancerValentina Turinetto, Barbara Pardini, Alessandra Allione, et al.
Gastroenterology|June 1, 2023
A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter StudyBarbara Pardini, Giulio Ferrero, Sonia Tarallo, et al.
The Journal of Pathology|January 18, 2024
A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restrictionGil A Pastorino, Ilir Sheraj, Kerstin Huebner, et al.
Plos One|March 8, 2012
A comprehensive investigation on common polymorphisms in the MDR1/ABCB1 transporter gene and susceptibility to colorectal cancerDaniele Campa, Juan Sainz, Barbara Pardini, et al.
Molecular Medicine (Cambridge, Mass.)|April 2, 2022
Combined miRNA and SERS urine liquid biopsy for the point-of-care diagnosis and molecular stratification of bladder cancerTudor Moisoiu, Mihnea P Dragomir, Stefania D Iancu, et al.
International Journal of Cancer|April 5, 2013
Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapyCarlotta Sacerdote, Simonetta Guarrera, Fulvio Ricceri, et al.
BMC Gastroenterology|October 6, 2010
Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control studyDaniele Campa, Barbara Pardini, Alessio Naccarati, et al.
British Journal of Cancer|June 12, 2026
Fecal immunochemical tests from population-based colorectal cancer screening programs support prospective microbiome cohortsDoratha A Byrd, Sémi Zouiouich, David Wahl, et al.
Plos One|June 16, 2011
Association between TAS2R38 gene polymorphisms and colorectal cancer risk: a case-control study in two independent populations of Caucasian originMaura Carrai, Verena Steinke, Pavel Vodicka, et al.
Pageof 13